切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2022, Vol. 18 ›› Issue (02) : 165 -174. doi: 10.3877/cma.j.issn.1673-5250.2022.02.007

论著

微小RNA-195靶向趋化因子5抑制滋养细胞增殖、迁移和侵袭及其机制研究
程慧, 李妍雨, 张蓓, 成杰, 张艳玲†()   
  1. 徐州市中心医院妇产科　221009
  • 收稿日期:2021-04-08 修回日期:2022-02-27 出版日期:2022-04-01
  • 通信作者: 张艳玲

MicroRNA-195 targeting chemokine 5 inhibits proliferation, metastasis and invasion of trophoblast cells and its mechanism

Hui Cheng, Yanyu Li, Bei Zhang, Jie Cheng, Yanling Zhang†()   

  1. Department of Obstetrics and Gynecology, Xuzhou Central Hospital, Xuzhou 221009, Jiangsu Province, China
  • Received:2021-04-08 Revised:2022-02-27 Published:2022-04-01
  • Corresponding author: Yanling Zhang
  • Supported by:
    Scientific Research Plan of Jiangsu Provincial Health and Family Planning Commission(F201662)
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

程慧, 李妍雨, 张蓓, 成杰, 张艳玲. 微小RNA-195靶向趋化因子5抑制滋养细胞增殖、迁移和侵袭及其机制研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 165-174.

Hui Cheng, Yanyu Li, Bei Zhang, Jie Cheng, Yanling Zhang. MicroRNA-195 targeting chemokine 5 inhibits proliferation, metastasis and invasion of trophoblast cells and its mechanism[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(02): 165-174.

目的

探讨微小RNA(miR)-195通过靶向调控趋化因子(CCL)5对胎盘滋养细胞增殖、侵袭的影响及其分子机制。

方法

采用随机数字表法，选取2018年8月至2019年8月在徐州市中心医院定期产前检查的70例孕妇，按照是否合并子痫前期(PE)，将其分为PE组(n＝40)和对照组(n＝30)。选取2组受试者分娩时自胎盘母-胎界面组织中分离的滋养细胞株HTR-8/SVneo细胞为研究对象，针对PE组胎盘滋养层细胞分别转染miR-195及RNA阴性对照序列。根据转染结果，将PE组胎盘滋养层细胞分为miR-195 mimics亚组、miR-NC亚组、miR-195+pcDNA亚组、miR-195+pcDNA-CCL5亚组。采用实时荧光定量聚合酶链式反应(RT-PCR)检测研究组与对照组胎盘组织中miR-195、CCL5 mRNA相对表达水平；MTT实验检测各亚组滋养细胞增殖能力，Transwell侵袭实验观察细胞侵袭能力，细胞划痕实验观察各亚组滋养细胞迁移能力，Western blotting法检测CCL5、PI3K及AKT蛋白相对表达水平；Pearson相关性分析对miR-195及CCL5表达相关性进行分析；荧光素酶实验验证miR-195与CCL5的靶向关系。本研究遵循的程序符合徐州市中心医院伦理委员会规定，通过该伦理委员会审查，并获得批准(审批文号：XZXY-LI-20181215-031)。所有受试者均签署临床研究知情同意书。

结果

①PE组和对照组孕妇年龄、孕龄等一般临床资料比较，差异无统计学意义(P>0.05)。2组孕妇血压及尿蛋白水平比较，差异有统计学意义(P<0.05)。②PE组患者胎盘组织中miR-195 mRNA相对表达水平高于对照组(t＝10.932，P<0.001)；PE组患者胎盘组织中CCL5 mRNA、蛋白相对表达水平低于对照组(t＝11.125、13.253，P<0.001)。③miR-195 mimics亚组滋养细胞中miR-195相对表达水平高于miR-NC亚组(P<0.001)，miR-195 mimics亚组第1、2、3、4天细胞活力低于miR-NC亚组，并且差异均有统计学意义(P<0.05)。④细胞培养72 h后，miR-195 mimics亚组侵袭细胞数、细胞迁移率均低于miR-NC亚组，并且差异均有统计学意义(t＝11.327，18.357，P<0.001)。⑤miR-195 mimics亚组细胞CCL5蛋白相对表达水平低于miR-NC亚组(P<0.001)；miR-195 mRNA水平与CCL5蛋白相对表达水平呈负相关关系(r＝-0.326，P<0.001)。⑥miR-195 mimics亚组细胞中PI3K和AKT蛋白相对表达水平低于miR-NC亚组；miR-195+pcDNA-CCL5亚组细胞中PI3K和AKT蛋白相对表达水平均高于miR-195+pcDNA亚组，并且差异均有统计学意义(P<0.05)。

结论

miR-195可能通过抑制CCL5的表达，进而抑制其下游PI3K/AKT信号通路的活化，最终影响滋养细胞的侵袭及迁移能力，从而导致PE的发生。

关键词: 微RNAs, 微小RNA-195, 趋化因子CCL5, 滋养细胞, 细胞增殖, 侵袭, 先兆子痫
Objective

To investigate effects of microRNA (miR)-195 on the proliferation and invasion of trophoblast cells by targeting chemokine (CCL)5 and its molecular mechanism.

Methods

Forty pre-eclampsia (PE) pregnant women (PE group) and 30 healthy pregnant women (control group) were selected by randon number table method. The trophoblast cell line HTR-8/SVneo was transfected with miR-195 and RNA-negative control sequences, respectively. According to the transfer results, placental trophoblast cells in PE group were divided into miR-195 mimics subgroup, miR-NC subgroup, miR-195+ pcDNA subgroup, miR-195+ pcDNA-CCL5 subgroup. Real-time polymerase chain reaction (RT-PCR) was used to detect the expression level of miR-195, CCL5 mRNA. The cell proliferation ability of each group was detected by MTT. The cell invasion ability was detected by Transwell invasion experiment. The ability of cell migration in each group was observed by cell scratch test. The expression of CCL5, PI3K and AKT protein in each group were detected by Western blotting. The correlation between the expressions of miR-195 and CCL5 was analyzed by Pearson correlation analysis. Luciferase experiment was used to verify the targeting relationship between miR-195 and CCL5. The procedure followed in this study met the standards formulated by the Ethics Review Committee of Xuzhou Central Hospital and has been approved by it (Approval No. KS2204). Informed consent was obtained from each participant.

Results

①There was no significant difference between PE group and control group in general clinical data such as age, gestational age (P>0.05). The blood pressure and urine protein levels of pregnant women in two groups were significantly different (P<0.05). ②The relative expression level of miR-195 mRNA in placental tissue of PE group was higher than that of control group (t=10.932, P<0.001), and the relative expression of CCL5 mRNA and protein in placental tissue of PE group were lower than those of control group (t=11.125, 13.253; P<0.001). ③The level of miR-195 in miR-195 mimics subgroup was higher than that in miR-NC subgroup (P<0.001). The activity of cells on 1, 2, 3, 4 d in miR-195 mimics subgroup were lower than those in miR-NC subgroup (P<0.05). ④After the cells were cultured for 72 h, the number of invasive cells and cell mobility in miR-195 mimics subgroup were lower than those in miR-NC subgroup, and the differences were statistically significant (t=11.327, 18.357, P<0.001). ⑤The relative expression level of CCL5 protein in miR-195 mimics subgroup was lower than that in miR-NC subgroup (P<0.001). The relative expression level of miR-195 mRNA was negatively correlated with the relative expression level of CCL5 protein (r=-0.326, P<0.001). ⑥The relative expression level of PI3K and AKT in miR-195 mimics subgroup was lower than that in miR-NC subgroup (P<0.05). The relative expression level of PI3K and AKT in miR-195+ pcDNA-CCL5 subgroup was higher than that in miR-195 pcDNA subgroup (P<0.05).

Conclusions

miR-195 may inhibit the activation of PI3K/AKT signaling pathway by inhibiting the expression of CCL5, affecting the invasion and migration ability of trophoblasts contributing to the development of PE.

Key words: MicroRNAs, microRNA-195, Chemokine CCL5, Trophoblast cells, Cell proliferation, Invasion, Pre-eclampsia
表1 CCL5、miR-195、U6目标基因引物序列
目标基因 上游引物序列 下游引物序列
CCL5 5′-CAGCAAACGCAAGGATGTC-3′ 5′-AAGGCGTAGAGAACGGGATT-3′
miR-195 5′-ATAACCTACCAGCGCCGAATTCGGGACCA-3′ 5′-ACCACCGACTTGTGACA-3′
U6 5′-TATTGACATTAGTTAAT-3′ 5′-TTTAGAAGACTCCCTAGAGTA-3′
表1 2组受试者一般临床资料比较(±s)
组别 例数 年龄(岁) 孕龄(周)
PE组 40 30.3±2.6 37.5±3.5
对照组 30 29.4±3.1 37.6±2.7
t值   1.235 1.002
P值   0.159 0.202
表2 2组孕妇血压及尿蛋白水平比较(±s)
组别 例数 收缩压(mmHg) 舒张压(mmHg) 24 h尿蛋白(g/24 h)
PE组 40 169.6±6.8 114.5±4.3 5.7±1.1
对照组 30 111.7±8.1 69.1±5.2 0±0
t值   9.032 12.549 14.861
P值   <0.001 <0.001 <0.001
表3 2组孕妇胎盘组织中miR-195 mRNA、CCL5 mRNA及CCL5蛋白相对表达水平比较(%，±s)
组别 例数 miR-195 mRNA CCL5 mRNA CCL5蛋白
PE组 40 89.2±11.3 28.8±1.4 1.3±0.5
对照组 30 40.2±6.4 61.1±5.3 4.3±0.8
t值   10.932 11.125 13.253
P值   <0.001 <0.001 <0.001
表4 胎盘滋养细胞中miR-195过表达对滋养细胞增殖的影响(±s)
组别 miR-195 细胞活力
0 d 1 d 2 d 3 d 4 d
miR-195 mimics亚组 3.803±0.243 0.401±0.038 0.513±0.182 0.593±0.078 0.792±0.304 0.903±0.331
miR-NC亚组 0.267±0.023 0.398±0.044 0.611±0.284 0.803±0.053 1.258±0.195 1.583±0.477
t值 49.834 0.162 2.834 3.023 4.103 4.834
P值 <0.001 0.624 0.026 0.013 0.008 0.003
表5 胎盘滋养细胞中miR-195对滋养细胞侵袭、迁移的影响(±s)
组别 侵袭细胞数(个) 细胞迁移率(%)
miR-195 mimics亚组 78.3±6.3 22.1±2.5
miR-NC亚组 114.1±5.6 51.8±5.4
t值 11.327 18.357
P值 <0.001 <0.001
图1 miR-195与CCL5的靶向关系(图1A：双荧光素酶结果；图1B：miR-195与CCL5的靶向结合位点预测图)注：CCL5 WT为野生型CCL5基因序列质粒，CCL5 MUT1为突变型CCL5基因序列质粒1，CCL5 MUT2为突变型CCL5基因序列质粒2，miR-195 mimics为miR-195过表达质粒，CCL5 mut为突变型CCL5序列，miR-195为微小RNA-195，CCL5为趋化因子5
图2 胎盘滋养细胞中miR-195过表达对CCL5蛋白的影响(图2A：Western blotting法检测miR-195 mimics亚组与miR-NC亚组滋养细胞CCL5蛋白表达电泳条带图；图2B：miR-195 mimics亚组与miR-NC亚组滋养细胞CCL5蛋白相对表达水平；图2C：miR-195 mRNA相对表达水平与CCL5蛋白相对表达水平相关性分析散点图)注：①为miR-195 mimics亚组，②为miR-NC亚组；miR-195为微小RNA-195，CCL5为趋化因子5
图3 miR-195调控CCL5影响滋养细胞PI3K/AKT通路(图3A：Western blotting法检测4个亚组滋养细胞PI3K和AKT蛋白表达电泳条带图；图3B：4个滋养细胞亚组PI3K和AKT蛋白相对表达水平)注：①为miR-195 mimics亚组，②为miR-195+pcDNA亚组，③为miR-NC亚组，④为miR-195+pcDNA-CCL5亚组。miR-195为微小RNA-195，CCL5为趋化因子5
图4 miR-195调控CCL5影响滋养细胞p-PI3K、p-AKT蛋白作用(图4A：Western blotting法检测4个亚组滋养细胞p-PI3K和p-AKT蛋白表达电泳条带图；图4B：4个亚组滋养细胞p-PI3K和p-AKT蛋白相对表达水平)注：①为miR-195 mimics亚组，②为miR-195+pcDNA亚组，③为miR-NC亚组，④为miR-195+pcDNA-CCL5亚组。miR-195为微小RNA-195，CCL5为趋化因子5
表6 4个亚组滋养细胞PI3K、p-PI3K和AKT、p-AKT蛋白相对表达水平(%，±s)
组别 PI3K p-PI3K AKT p-AKT
miR-195 mimics亚组 30.4±7.2 26.4±6.7 11.3±3.3 24.4±4.2
miR-195+pcDNA亚组 43.2±10.1 35.3±8.3 21.1±6.3 30.9±5.5
miR-NC亚组 68.2±1.3 51.8±9.3 37.4±2.2 49.2±7.1
miR-195+pcDNA-CCL5亚组 70.1±11.6 69.7±10.2 41.7±9.3 58.7±8.4
[1]
漆洪波，童超．从母胎界面着眼探究子痫前期的发病机制[J]．中国实用妇科与产科杂志，2020，36(1): 61-64. DOI：10.19538/j.fk2020010115.
[2]
董环，郝冉，宋园园，等. 慢性疼痛相关MicroRNA的研究进展[J]. 实用医学杂志，2018，34(8): 1390-1393. DOI：10.3969/j.issn.1006-5725.2018.08.042.
[3]
MA YY, Liang XX, Wu H, et al. Long non-coding RNA NR_002794 is up-regulated in pre-eclampsia and regulates the proliferation, apoptosis and invasion of trophoblast cells[J]. Mol Med Rep, 2019, 20(5): 4567-4575. DOI: 10.3892/mmr.2019.10701
[4]
Han L, Luo QQ, Peng MG, et al. miR-483 is downregulated in pre-eclampsia via targeting insulin-like growth factor 1 (IGF1) and regulates the PI3K/Akt/mTOR pathway of endothelial progenitor cells[J]. J Obstet Gynaecol Res, 2020, 47(1): 63-72. DOI: 10.1111/jog.14412.
[5]
Wu L, Song WY, Xie Y, et al. miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2[J]. Cell Death Dis, 2018, 9(2): 16. DOI: 10.1038/s41419-017-0045-0.
[6]
Zuo W, Zhang W, Xu F, et al. Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1[J]. Cancer Cell Int, 2019, 12(19)：240.
[7]
Yu X, Zhang Y, Wu B, et al. The miR-195 axis regulates chemoresistance through TUBB and lung cancer progression through BIRC5[J]. Mol Ther Oncolytics, 2019, 14: 288-298. DOI: 10.1016/j.omto.2019.07.004.
[8]
Do HTT, Lee CH, Cho J. Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers[J]. Cancers (Basel), 2020, 12(2): 287. DOI: 10.3390/cancers12020287.
[9]
Eltounali SA, Moodley J, Naicker T. Role of kidney biomarkers [kidney injury molecule-1, calbindin, interleukin-18 and monocyte chemoattractant protein-1]in HIV associated pre-eclampsia[J]. Hypertens Pregnancy, 2017, 36(4): 288-294. DOI: 10.1080/10641955.2017.1385793.
[10]
谢幸，苟文丽．妇产科学[M].8版．北京：人民卫生出版社，2013: 64-71.
[11]
Han X, Niu C, Zuo Z, et al. MiR-342-3p inhibition promotes cell proliferation and invasion by directly targeting ID4 in pre-eclampsia[J]. J Obstet Gynaecol Res, 2020, 46(1): 49-57. DOI: 10.1111/jog.14150.
[12]
Tang H, Pan L, Xiong Y, et al. Down-regulation of the Sp1 transcription factor by an increase of microRNA-4497 in human placenta is associated with early recurrent miscarriage[J]. Reprod Biol Endocrinol, 2021, 19(1): 21. DOI: 10.1186/s12958-021-00701-8.
[13]
Niu ZR, Han T, Sun XL, et al. MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1[J]. Am J Obstet Gynecol, 2018, 218(2): 249. e1-249. e12. DOI: 10.1016/j.ajog.2017.11.568.
[14]
Wang X, He C, Yang Z, et al. Dysregulation of long non-coding RNA SNHG12 alters the viability, apoptosis, and autophagy of prostate cancer cells by regulating miR-195/CCNE1 axis[J]. Int J Clin Exp Pathol, 2019, 12(4): 1272-1283.
[15]
Yang K, Tang H, Ding M, et al. Expression of miR-195 and MEK1 in patients with bladder cancer and their relationship to prognosis[J]. Int J Clin Exp Pathol, 2019, 12(3): 843-850.
[16]
Zhao XM, Dai LL, Yue QF, et al. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4[J]．J Biosci, 2019, 44(6): 146. DOI：10.1007/s12038-019-9966-3.
[17]
彭美茜，徐丽云，杨丹，等. Drosha通过调控微RNA-195-5P促进胃癌细胞的迁移和侵袭[J]．肿瘤，2018，38(10): 925-932.
[18]
Naito Y, Yamamoto Y, Sakamoto N, et al. Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts[J]. Oncogene, 2019, 38(28): 5566-5579. DOI: 10.1038/s41388-019-0832-4.
[19]
Sebrell TA, Hashimi M, Sidar B, et al. A novel gastric spheroid co-culture model reveals chemokine-dependent recruitment of human dendritic cells to the gastric epithelium[J]. Cell Mol Gastroenterol Hepatol, 2019, 8(1): 157-171. e3. DOI: 10.1016/j.jcmgh.2019.02.010.
[20]
康玲，彭诗元，秦源，等. CCL28通过增强MMP-2活力促进滋养细胞浸润功能[J]．现代妇产科进展，2017，26(5): 337-341. DOI: 10.13283/j.cnki.xdfckjz.2017.05.005.
[21]
Li H, Meng YH, Shang WQ, et al. Chemokine CCL24 promotes the growth and invasiveness of trophoblasts through ERK1/2 and PI3K signaling pathways in human early pregnancy[J]. Reproduction, 2015, 150(5): 417-427. DOI: 10.1530/REP-15-0119.
[22]
达成利，帕拉提·艾斯卡，比力克孜·玉素甫. 趋化因子CCL5在涎腺腺样囊性癌患者肿瘤组织和血清中的表达及临床意义[J]．实用癌症杂志，2019，34(6)：891-894. DOI: 10.3969/j.issn.1001-5930.2019.06.006.
[23]
梁亮，邓骞，聂治军，等. 趋化因子CCL5表达与肾透明细胞癌病理特征及预后的相关性研究[J]．现代肿瘤医学，2018，26(3)：405-408. DOI: 10.3969/j.issn.1672-4992.2018.03.020.
[24]
Liu GT, Chen HT, Tsou HK, et al. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells[J]. Oncotarget, 2014, 5(21): 10718-10731. DOI: 10.18632/oncotarget.2532
[25]
Chao CC, Lee CW, Chang TM, et al. CXCL1/CXCR2 paracrine axis contributes to lung metastasis in osteosarcoma[J]. Cancers (Basel), 2020, 12(2): 459. DOI: 10.3390/cancers12020459.
[26]
Zhou B, Sun C, Li N, et al. Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways[J]. Int J Oncol, 2016, 48(5): 2087-2097. DOI: 10.3892/ijo.2016.3442.
[1] 魏艺, 周羽西, 杨烨, 凌秀凤, 赵纯. 微小RNA对子宫内膜容受性影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 266-270.
[2] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[3] 祝炜安, 林华慧, 吴建杰, 黄炯煅, 吴婷婷, 赖文杰. RDM1通过CDK4促进前列腺癌细胞进展的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 618-625.
[4] 赵蒙蒙, 黄洁, 余荣环, 王葆青. 过表达小GTP酶Rab32抑制非小细胞肺癌细胞侵袭性生长[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 512-518.
[5] 赵旭鹏, 王集琛, 田硕, 李宏召, 李修彬, 张旭. EP300 通过上调FKBP10 促进膀胱肿瘤细胞迁移和侵袭[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 264-274.
[6] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[7] 曾聿理, 雷发容, 肖慧, 邱德亮, 谢静, 吴寻. 氯普鲁卡因通过调控circRNA-ZKSCAN1表达抑制肝癌Huh-7细胞体外生长和转移的研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 220-228.
[8] 李晶, 潘侠, 周芳, 汪晶, 洪佳. 普鲁卡因通过上调lncRNA DGCR5抑制胃癌细胞增殖、迁移和侵袭[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 151-158.
[9] 刘杜先, 张杰东, 付鲁渝, 熊志强, 龚程, 张小雅, 高明悦, 孟俊宏, 刘兰侠. 沉默circXPO1抑制肝癌细胞恶性生物学行为[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 159-166.
[10] 李博, 马秀岩, 孙杰. lncRNA TINCR对滋养层HTR-8/SVneo细胞生物学行为的影响及其机制[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 167-172.
[11] 曾谣, 谢琴, 陈显育, 王平根, 毛玲秋, 何丹玲, 杜飞, 郑希彦, 何函樨. CDC42EP2基因与肝癌预后、免疫细胞浸润关系及其对细胞迁移侵袭的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 363-369.
[12] 杨兴业, 彭旭云, 曾倩, 梁伟铖, 肖翠翠, 郑俊, 姚嘉. LMO7通过靶向铁死亡促进肝细胞癌生长[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 370-376.
[13] 崔精, 鲍一帆, 沈晓明, 杨增辉, 高森, 鲍传庆. 结直肠癌中circMFSD12对肿瘤细胞功能及5-FU敏感性的调控[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 294-302.
[14] 朱镭, 朱庆义. 金氏菌属：引起婴幼儿侵袭性传染病的新发病原体[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 229-237.
[15] 张芳芳, 李军, 赵玉洁, 于彤, 宁春平. 侵袭性血管黏液瘤的影像学特征并文献复习[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 254-259.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？